Present evidence on the value of HPV testing for cervical cancer screening: A model-based exploration of the (cost-)effectiveness

British Journal of Cancer

Volumn 76, Issue 5, 1997, Pages 651-657

  Van Ballegooijen, M ^a,c   Van den Akker van Marle, M E ^a   Warmerdam, P G ^a   Meijer, Cjlm ^b   Walboomers, Jmm ^b   Habbema, Jdf ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Cost effectiveness; Human papilloma virus; Mass screening; Pap smear

Indexed keywords

ARTICLE; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; HUMAN; MORTALITY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

EID: 0030794704     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.440     Document Type: Article

References (33)

1. Ballegooijen M Van, Habbema JDF, Oortmarssen GJ Van, Koopmanschap MA, Lubbe JTHN and Agt HMA Van (1992 a) Preventive pap-smears: balancing costs, risks and benefits. Br J Cancer 65: 930-933
2. Ballegooijen M Van, Koopmanschap MA, Subandono Tjokrowrdojo AJ and Oortmarssen GJ Van (1992b) Care and costs for advanced cervical cancer. Eur J Cancer 28A: 1703-1708
3. Ballegooijen M Van, Koopmanschap MA and Habbema JDF (1995) The management of cervical intraepiThelial neoplasia: extensiveness and costs. Eur J Cancer 13A: 1672-1676
4. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, Cadell DM, Kurman RJ and Manos MM (1993) Determinants of genital Human Papillomavirus infection in low-risk women in Portland, Oregon. Sexually Transmitted Diseases 20: 274-278
5. Bergeron C, Barrasso R, Beaudenon S, Flamant P, Croissant O and Orth G (1992) Human papillomaviruses associated with cervical intra-epithelial neoplasia. Am J Surg Pathol 16: 641-649
6. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796-802
7. Brule AJC van den, Walboomers JMM, Maine M du, Kenemans P and Meijer CJLM (1991 ) Difference in prevalence of human papillomavirus genotypes in cytomorphological normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 48: 404-108
8. Cuzick J, Terry G, Ho L, Hollingworth T and Anderson M (1994) Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 69: 167-171
9. Cuziek J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST and Guilleband J (1995) Human papillomavirus testing in primary cervical cancer screening. Lancer 345: 1533-1536
10. Dutch Network and National Database for Pathology (PALGA) (1992) Results of Retrieval Action on Cervical Cytology from 1987-1990. SIG: Utrecht
11. Dutch Network and National Database for Pathology (PALGA) (1995) Results of Retrieval Action on Cervical Cytology from 1987-1990. SIG: Utrecht
12. Eluf-Neto J, Booth M, Muñz N, Bosch FX, Meijer CJLM and Walboomers JMM (1994) Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 69: 114-119
13. Gaarenstroom KN, Melken P, Walboomers MM, Brule AJC van den, Bommel PFJ van, Meyer CJLM, Voorhorst FJ, Kenemans P and Helmerhorst THJM (1994) Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynaecol Cancer 4: 73-78
14. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R and Romney S (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87: 1365-1371
15. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes (1986) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 293: 659-664
16. 1ARC Working Group (1995) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papilloma Viruses. IARC Scientific Publication no. 64. 1ARC: Lyon
17. Jensen OM, Esteve J, Moller H and Renard H (1990) Cancer in the European community and its member states. Eur J Cancer 26: 1167-1256
18. Jenkins D, Sherlaw-Johnson C and Gallivan S (1996) Can papilloma virus testing be used to improve cervical cancer screening? Int J Cancer 65: 768-773
19. Kjaer SK, Brule AJC van den, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JMM and Meijer CJLM (1996) Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 65: 601-606
20. Koopmanschap M, Lubbe JTHN, Oortmarssen GJ Van, AgT HMA van, Ballegooijen M Van and Habbema JDF (1990a) Economic aspects of cervical cancer screening. Soc Sci Med 30: 1081-1087
21. Koopmanschap M, Oortmarssen GJ van, Agt HMA van, Ballegooijen M van, Habbema JDF and Lubbe JTHN (1990b) Cervical-cancer screening: attendance and cost-effectiveness. Int J Cancer 45: 410-415
22. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster WD and Kurman RJ. (1992) Human papillomavirus infection of the cervix: relative risk associations of fifteen common anogenital types. Obstet Gynecol 79: 328-337
23. Melkert PWJ, Hopman E, Brule AJC van den, Risse EKJ, Diest PJ van, Bleker OP, Helmerhorst T, Schipper MEI, Meijer CJLM and Walboomers JMM (1993) Prevalence of HPV in cytomorphological normal cervical scrapes, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 53: 919-923
24. Morrison EAB, Ho GYF, Vermund SH, Goldberg GL, Kadish AS, Kelley KF and Burk RD (1991) Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 49: 6-13
25. Muñoz N, Bosch FX, Sanjosé S de, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N, Gonzalez LC, Kaldor JM, Guerrero E, Lörincz A, Santamaria M, Alfonso de Ruiz P, Aristizabal N and Shah K (1992) The causal link between human papillomavirus and invasive cervical cancer: a populationbased case-control study in Colombia and Spain. Int J Cancer 52: 743-749
26. Oortmarssen GJ van and Habbema JDF (1991) EpidemiologiC evidence for agedependent regression of pre-invasive cervical cancer. Br J Cancer 64: 559-565
27. Oortmarssen GJ Van and Habbema JDF (1995) The duration of pre-clinical cancer and the reduction in incidence of invasive cancer following negative Pap smears. Int J Epidemiol 24: 300-307
28. Parkin DM, Pisani P and Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54: 954-606
29. Remmink AJ, Walboomers JMM, Helmerhorst TJM, Voorhorst FJ, Rozendaal L, Risse EKJ, Meijer CJLM and Kenemans P (1995) The presence of persistent high risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306-311
30. Rozendaal L, Walboomers JMM, Linden JC van der, Voorhorst FJ, Kenemans P, Helmerhorst THJM, Ballegooijen M van and Meijer CJLM (1996) The PCRbased high risk HPV test in cervical cancer screening gives an objective risk assessment of women with cytomorphological normal cervical smears. Int J Cancer 68: 766-769
31. Sanjosé S de, Muñoz N, Bosch FX, Reimann K, Pedersen NS, Orfila J, Ascune N, Gonzalez LC, Tafur L, Gili M, Lette I, Viladiu P, Torino MJ, Moreo P, Shah K and Wahren B (1994) Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 56: 358-363
32. Walboomers JMM, Roda Husman AM de, Snijders PJF, Stel HV, Risse EKJ, Helmerhorst TJM, Voorhorst FJ and Meijer CJLM (1995) Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol 48: 728-732
33. Zur Hausen H (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In Human Pathogenic Papiltomaviruses, Zur Hausen H. (ed.), pp. 9-13. Springer: Berlin